Prescription drugs; price transparency.
Do you support it?
Want to know if it passes?
We'll email you when HB 876 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HB 876.
You're tracking HB 876
We'll email you the moment it moves.
HB 876 — Prescription drugs; price transparency.
Last action — Left in Health, Welfare and Institutions
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed House of Delegates
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 2021 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Prescription drug price transparency. Requiresevery health carrier, pharmacy benefits manager, wholesale drug distributer, and drug manufacturer to report information about prescription drugprices and related information to the Department of Health and requiresthe Department to make such information available on its website.
Bill Text
- Prefiled Prefiled and ordered printed; offered 01/08/20 20104912D Current html January 07, 2020
Action History
-
Left in Health, Welfare and Institutions
-
Continued to 2021 with substitute in Health, Welfare and Institutions
-
Subcommittee recommends continuing to 2021
-
House committee, floor amendments and substitutes offered
-
Impact statement from DPB (HB876)
-
Assigned HWI sub: Health Professions
-
Referred to Committee on Health, Welfare and Institutions
-
Prefiled and ordered printed; offered 01/08/20 20104912D
Sponsors
- Shelly A. Simonds · Cosponsor
- Chris L. Hurst · Cosponsor
- Suhas Subramanyam · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 2 co-sponsors · 145 not signed on
Sponsors (1)
Co-sponsors (2)
Not signed on (145)
145 members have not signed on to this bill.
Show all 145 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
Roll call published as PDF — view source.
Roll call published as PDF — view source.
Roll call published as PDF — view source.
Subjects
Frequently asked questions
- What does HB 876 do?
- Prescription drug price transparency. Requiresevery health carrier, pharmacy benefits manager, wholesale drug distributer, and drug manufacturer to report information about prescription drugprices and related information to the Department of Health and requiresthe Department to make such information available on its website.
- Who sponsors HB 876?
- HB 876 is sponsored by Shelly A. Simonds, Hurst, Chris L., and Subramanyam, Suhas.
- What is the current status of HB 876?
- This bill died with 2021 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HB 876?
- Track HB 876 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 876
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 876
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →